Seminarios de la Fundación Española de Reumatología
2016
Biological therapies may herald the cure for rheumatoid arthritis. Targeted biologic therapies have changed the outcome of this disease. Tocilizumab is a humanized monoclonal antibody against the interleukin-6 receptor and has been approved in many countries for the treatment of moderate to severe rheumatoid arthritis. A number of clinical trials have demonstrated the efficacy of tocilizumab in active
Keywords:
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
23
References
0
Citations
NaN
KQI